| SKU | Size | Availability | Price | Qty |
|---|---|---|---|---|
| Ab121327-10μl | 10μl | In stock | $76.90 | |
| Ab121327-50μl | 50μl | In stock | $229.90 | |
| Ab121327-100μl | 100μl | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $369.90 | |
| Ab121327-1ml | 1ml | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $2,999.90 |
Recombinant; Rabbit anti Human Peroxiredoxin 3/PRDX3 Antibody; WB, ICC, IF, IHC; Unconjugated
| Product Name | Recombinant Peroxiredoxin 3/PRDX3 Antibody - Primary antibody, specific to Peroxiredoxin 3/PRDX3, Rabbit IgG |
|---|---|
| Synonyms | AOP1 | PPPCD | PRO1748 | SCAR32 | SP-22 | Antioxidant protein 1MGC104387 | AOP-1 | AOP-1MGC24293 | AOP1PRO1748 | EC 1.11.1.15 | HBC189 | MER5 | Peroxiredoxin 3 | Peroxiredoxin III | peroxiredoxin-3 | PRDX3 | Protein MER5 homolog | prx-III | thioredoxin-de |
| Specifications & Purity | ExactAb™, Validated, Recombinant, 0.2 mg/mL |
| Host species | Rabbit |
| Specificity | Peroxiredoxin 3/PRDX3 |
| Immunogen | A synthetic peptide derived from human Peroxiredoxin 3/PRDX3 (AA 243-256) |
| Positive Control | WB: HeLa, A431, MOLT-4, Hep G2 and MCF7 cell lysates. ICC/IF: HeLa cells. IHC: Human cholangiocarcinoma tissue. |
| Conjugation | Unconjugated |
| Grade | ExactAb™, Recombinant, Validated |
| Product Description | MAP3K13 to regulate the activation of NF-kappa-B in the cytosol.Rabbit anti Human Peroxiredoxin 3/PRDX3 Antibody, Recombinant, could be used for WB, ICC, IF, IHC and so on.Application |
| Isotype | Rabbit IgG |
|---|---|
| SDS-PAGE | 150 kDa |
| Purification Method | Antigen affinity purified |
| Form | Liquid |
| Concentration | 0.2 mg/mL |
| Storage Temp | Store at -20°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at 4°C short term (1-2 weeks). Store at -20°C long term (24 months). Upon delivery aliquot. Avoid freeze/thaw cycle. |
Recombinant Peroxiredoxin 3/PRDX3 Antibody (Ab121327) - Western Blot
All lanes: Recombinant Peroxiredoxin 3/PRDX3 Antibody (Ab121327) at 1/1000 dilution
Samples: Lysates at 20 µg per lane
Secondary: Goat Anti-Rabbit IgG H&L (HRP) (Ab170144) at 1/20000 dilution
Predicted band size: 28 kDa
Observed band size: 23 kDa
Exposure time: 8.6 s
Recombinant Peroxiredoxin 3/PRDX3 Antibody (Ab121327) - IF/ICC
Immunocytochemistry analysis of Peroxiredoxin 3 (green) in HeLa using Recombinant Peroxiredoxin 3/PRDX3 Antibody (Ab121327), and cells were counterstained with DAPI (blue).
Recombinant Peroxiredoxin 3/PRDX3 Antibody (Ab121327) - IHC
Immunohistochemistry analysis of paraffin-embedded Human Cholangiocarcinoma using Recombinant Peroxiredoxin 3/PRDX3 Antibody (Ab121327). High-pressure and temperature Sodium Citrate pH 6.0 was used for antigen retrieval.
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Application | Dilution info |
|---|---|
| WB | 1/500-1/1000 |
| IF/ICC |
1/50-1/200
|
| IHC | 1/50 - 1/100 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
 ZJ24F0303040 | Certificate of Analysis | Mar 08, 2024 | Ab121327 |
| ZJ23F1202161 | Certificate of Analysis | Dec 20, 2023 | Ab121327 |
| ZJ23F1202162 | Certificate of Analysis | Dec 20, 2023 | Ab121327 |
| 1. Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV, Mann M. (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions.. Science, 325 (5942): (834-40). [PMID:19608861] |
| 2. Tan L, Gurbani D, Weisberg EL, Jones DS, Rao S, Singer WD, Bernard FM, Mowafy S, Jenney A, Du G et al.. (2017) Studies of TAK1-centered polypharmacology with novel covalent TAK1 inhibitors.. Bioorg Med Chem, 25 (4): (1320-1328). [PMID:28038940] |
| 3. Hochstrasser, D F DF and 9 more authors.. (1992) Human liver protein map: a reference database established by microsequencing and gel comparison.. Electrophoresis, [PMID:1286669] |
| 4. Tsuji, K K, Copeland, N G NG, Jenkins, N A NA and Obinata, M M.. (1995) Mammalian antioxidant protein complements alkylhydroperoxide reductase (ahpC) mutation in Escherichia coli.. The Biochemical journal, (15): [PMID:7733872] |
| 5. Wagner, Elsa E and 6 more authors.. (2002) A method for detection of overoxidation of cysteines: peroxiredoxins are oxidized in vivo at the active-site cysteine during oxidative stress.. The Biochemical journal, (15): [PMID:12059788] |
| 6. Masaki, Megumi M, Ikeda, Atsushi A, Shiraki, Eriko E, Oka, Shogo S and Kawasaki, Toshisuke T.. (2003) Mixed lineage kinase LZK and antioxidant protein-1 activate NF-kappaB synergistically.. European journal of biochemistry, [PMID:12492477] |
| 7. Deloukas, P P and 135 more authors.. (2004) The DNA sequence and comparative analysis of human chromosome 10.. Nature, (27): [PMID:15164054] |
| 8. Liu, Lingling L and 8 more authors.. (2005) RPK118, a PX domain-containing protein, interacts with peroxiredoxin-3 through pseudo-kinase domains.. Molecules and cells, (28): [PMID:15750338] |
| 9. Cao, Zhenbo Z, Bhella, David D and Lindsay, J Gordon JG.. (2007) Reconstitution of the mitochondrial PrxIII antioxidant defence pathway: general properties and factors affecting PrxIII activity and oligomeric state.. Journal of molecular biology, (28): [PMID:17707404] |
| 10. Cox, Andrew G AG, Peskin, Alexander V AV, Paton, Louise N LN, Winterbourn, Christine C CC and Hampton, Mark B MB.. (2009) Redox potential and peroxide reactivity of human peroxiredoxin 3.. Biochemistry, (14): [PMID:19462976] |
| 11. Vaz Meirelles, Gabriela G and 5 more authors.. (2010) Characterization of hNek6 interactome reveals an important role for its short N-terminal domain and colocalization with proteins at the centrosome.. Journal of proteome research, (3): [PMID:20873783] |
| 12. Angeles, Dario C DC and 10 more authors.. (2011) Mutations in LRRK2 increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress-induced neuronal death.. Human mutation, [PMID:21850687] |
| 13. Yewdall, N Amy NA and 5 more authors.. (2018) Quaternary structure influences the peroxidase activity of peroxiredoxin 3.. Biochemical and biophysical research communications, (4): [PMID:29438714] |
| 14. Alió Del Barrio, Jorge L and 10 more authors.. (2020) Punctiform and Polychromatic Pre-Descemet Corneal Dystrophy: Clinical Evaluation and Identification of the Genetic Basis.. American journal of ophthalmology, [PMID:31782998] |
